Tuesday, February 25News That Matters
Shadow

F.D.A. Reviews Nonprescription Claritin

F.D.A. Reviews Nonprescription Claritin

Food and Drug Administration says efforts by Schering-Plough Corp to introduce nonprescription Claritin allergy drug may be delayed while it reviews reports of birth defects in babies born to Swedish women who took drug while pregnant (S)

Read More…



Leave a Reply

Your email address will not be published. Required fields are marked *